Published in Diabet Med on March 01, 1988
Primary, secondary and tertiary prevention of non-insulin-dependent diabetes. Postgrad Med J (1994) 0.87
Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol (2015) 0.84
Lipids in non-insulin dependent diabetes: a case for treatment? J R Soc Med (1991) 0.82
Treatment of diabetes: the effect on serum lipids and lipoproteins. Postgrad Med J (1991) 0.77
The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy. J R Soc Med (1989) 0.76
Specific lipid lowering therapy in the management of diabetes. Postgrad Med J (1991) 0.75
Enzymatic determination of total serum cholesterol. Clin Chem (1974) 20.65
Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem (1973) 3.69
Laboratory blunders revisited. Ann Clin Biochem (1994) 2.13
High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med (1992) 1.66
Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia (2000) 1.54
Effect of oestrogens on human platelet behaviour. Lancet (1968) 1.49
Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem (1998) 1.44
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study. Diabetes Care (1998) 1.38
Contribution of hyperoxia to lipid peroxidation in coronary artery operations: should we keep a low oxygen tension? J Thorac Cardiovasc Surg (1997) 1.38
The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. Diabetes Care (1998) 1.28
Effect of treatment of hyperlipidaemia on haemostatic variables. Br Med J (1980) 1.20
Effects of smoking on oral fat tolerance and high density lipoprotein cholesterol. Clin Sci (Lond) (1983) 1.18
Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf) (1997) 1.11
Factors predisposing to and outcome of gestational diabetes. Obstet Gynecol (1989) 1.10
Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis (2001) 1.06
Hypoglycaemia in an inner-city accident and emergency department: a 12-month survey. Arch Emerg Med (1989) 1.04
Impaired intravascular lipolysis with changes in concentrations of high density lipoprotein subclasses in young smokers. Br Med J (Clin Res Ed) (1987) 1.03
The genito-urinary manifestations of herpes zoster. Three case reports and a review of the literature. Br J Urol (1974) 1.02
The effect of diet and insulin on metabolic profiles of women with gestational diabetes mellitus. Diabetes (1985) 0.99
The effect of heparin in vitro on human plasm post-heparin lipolytic activity. Clin Chim Acta (1975) 0.95
Lipoprotein lipase deficiency due to long-term heparinization presenting as severe hypertriglyceridaemia in pregnancy. Postgrad Med J (1991) 0.93
Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care (2000) 0.93
Effect of a pyrimido-pyrimidine compound on platelet behaviour in vitro and in vivo. Lancet (1968) 0.92
The association of coronary calcium score and conventional cardiovascular risk factors in Type 2 diabetic subjects asymptomatic for coronary heart disease (The PREDICT Study). Diabet Med (2004) 0.91
Total antioxidant status and coronary artery calcification in type 1 diabetes. Diabetes Care (2001) 0.90
The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabet Med (1991) 0.90
Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects. J Hum Hypertens (1990) 0.89
Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol (Oxf) (1996) 0.88
Effect of treatment of hypertriglyceridaemia on high and low density lipoprotein cholesterol concentrations. Lancet (1979) 0.87
High-density lipoprotein composition and paraoxonase activity in Type I diabetes. Clin Sci (Lond) (2001) 0.87
Evidence for an hepatic anti-ketogenic effect of insulin in man. Clin Sci Mol Med (1978) 0.86
Calorie restriction for treatment of gestational diabetes. Diabetes (1991) 0.85
Myocardial injury in major aortic surgery. J Vasc Surg (2000) 0.85
Proceedings: The development of an enzymic technique for the assay of cholesterol in biological fluids. Clin Sci Mol Med (1974) 0.85
Use of cholesterol oxidase for assay of total and free cholesterol in serum by continuous-flow analysis. Clin Chem (1976) 0.85
Beta-blockers, lipoproteins and non-insulin dependent diabetes. Postgrad Med J (1988) 0.85
The effect of insulin on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate concentrations in human plasma. Clin Sci Mol Med (1976) 0.84
Heroin and hyperkalaemia. Lancet (1981) 0.84
Type 2 diabetes presenting as diabetic ketoacidosis in adolescence. Diabet Med (2003) 0.84
Serum-insulin in acromegaly. Lancet (1969) 0.83
Lipids in non-insulin dependent diabetes: a case for treatment? J R Soc Med (1991) 0.82
Lipoprotein lipase in human adipose tissue. Clin Sci Mol Med (1974) 0.82
The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes. Diabet Med (1988) 0.82
Acute changes in atherogenic and thrombogenic factors with cessation of smoking. J R Soc Med (1990) 0.82
Arterial wall changes in type 2 diabetic subjects. Diabet Med (1994) 0.82
Can protein biomarkers provide an index of coronary artery calcification in patients with Type 2 diabetes? Atherosclerosis (2010) 0.81
Prostaglandin E 1 and human platelets. Lancet (1969) 0.81
Total antioxidant status, protein glycation, lipid hydroperoxides in non insulin dependent diabetes mellitus. Biochem Soc Trans (1997) 0.81
Abnormalities of glucose tolerance following gestational diabetes. Q J Med (1990) 0.81
Lipid modification and coronary heart disease in type 2 diabetes: different from the general population? Heart (1999) 0.81
Hepatic and lipoprotein lipases selectively assayed in postheparin plasma. Clin Chem (1993) 0.80
High density lipoproteins, diabetes and diabetic macrovascular disease. Diabet Med (1985) 0.80
Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes. Diabet Med (2002) 0.80
Dietary lipids: an additional regulator of plasma levels of sex hormone binding globulin. J Clin Endocrinol Metab (1987) 0.79
Plasma adenosine 3':5'-cyclic monophosphate response to glucagon in thyroid disease. Clin Sci Mol Med (1975) 0.79
Correlation between carotid artery distensibility and serum vascular endothelial growth factor concentrations in type 1 diabetic subjects and nondiabetic subjects. Metabolism (2001) 0.79
The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab (1995) 0.79
The effects of fasting and streptozotocin diabetes on hepatic triglyceride lipase activity in the rat. Diabetes (1977) 0.78
The relationship between active renin concentration and plasma renin activity in Type 1 diabetes. Diabet Med (2001) 0.78
Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study. Diabet Med (2006) 0.78
The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Diabetologia (1978) 0.78
Lipid peroxidation, antioxidant status and troponin-T following cardiopulmonary bypass. A comparison between intermittent crossclamp with fibrillation and crystalloid cardioplegia. Eur J Cardiothorac Surg (1997) 0.78
The effect of hypolipidaemic therapy on serum uric acid concentration. Atherosclerosis (1976) 0.78
Diabetic hypertension--the importance of fibrinogen and blood viscosity. J Hum Hypertens (1988) 0.78
Treatment of diabetes: the effect on serum lipids and lipoproteins. Postgrad Med J (1991) 0.77
Hypertriglyceridaemia and hyperuricaemia. Lancet (1977) 0.77
Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy. J Clin Endocrinol Metab (1997) 0.77
Aspects of metabolism in normal and gestational diabetic pregnancy. Biochem Soc Trans (1995) 0.77
Analysis of high density lipoprotein subclasses by a precipitation procedure: comparison with preparative ultracentrifuge. Clin Chim Acta (1982) 0.77
Serum insulin, glucose, and lipid levels among mild diabetics in relation to incidence of vascular complications. Lancet (1971) 0.77
Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clin Endocrinol (Oxf) (1998) 0.77
Serum lipids and apolipoproteins and their relationship with macrovascular disease in type 1 diabetes. Diabet Med (1994) 0.76
Ethnic differences in insulin secretion in women at risk of future diabetes. Diabet Med (1992) 0.76
Regulation of hepatic lipase expression in HepG2 cells. Biochem Soc Trans (1997) 0.76
A defect in insulin release in women at risk of future non-insulin-dependent diabetes. Clin Sci (Lond) (1991) 0.76
Determinants of mild fasting hypertriglyceridaemia in non-insulin-dependent diabetes. J Intern Med (1991) 0.76
Blood rheology and cardiovascular risk factors in type 1 diabetes: relationship with microalbuminuria. Diabet Med (1991) 0.76
Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes. Clin Endocrinol (Oxf) (1991) 0.76
Chlorpropamide lowers serum and lipoprotein cholesterol in insulin-dependent diabetes. Diabet Med (1986) 0.76
Reduced postprandial energy expenditure in women predisposed to type 2 diabetes. Diabet Med (1994) 0.76
The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy. J R Soc Med (1989) 0.76
Feedback inhibition of insulin secretion in type 2 diabetes. Clin Sci (Lond) (1991) 0.76
Towards a definitive assay of creatinine in serum and in urine: separation by high-performance liquid chromatography. J Chromatogr (1978) 0.76